SB 548 (see companion bill AB 555) – Wisconsin

Status: Inactive / Dead
Year Introduced: 2021

An Act to create 601.31 (1) (nv) and 632.863 of the statutes; Relating to: licensure of pharmaceutical representatives. This bill requires a pharmaceutical representative to be licensed by the Office of the Commissioner of Insurance and to display his or her license during each visit with a health care professional. The bill defines “pharmaceutical representative” to mean an individual who markets or promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical manufacturer for compensation. The bill requires that a pharmaceutical representative, during each contact with a health care professional, disclose the wholesale acquisition cost of any pharmaceuticals discussed and the names of at least three generic prescription drugs from the same therapeutic class.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found